Gail M Farfel's Net Worth
$1.65 Million
Who is Gail M Farfel?
Gail M Farfel has an estimated net worth of $1.65 Million. This is based on reported shares across multiple companies, which include ZOGENIX, INC., MARINUS PHARMACEUTICALS INC, DURECT CORP, AVROBIO, Inc., and ProMIS Neurosciences Inc..
SEC CIK
Gail M Farfel's CIK is 0001614780
Past Insider Trading and Trends
2022 was Gail M Farfel's most active year for acquiring shares with 14 total transactions. Gail M Farfel's most active month to acquire stocks was the month of February. 2018 was Gail M Farfel's most active year for disposing of shares, totalling 12 transactions. Gail M Farfel's most active month to dispose stocks was the month of February. 2018 saw Gail M Farfel paying a total of $362,415.56 for 72,461 shares, this is the most they've acquired in one year. In 2015 Gail M Farfel cashed out on 60,000 shares for a total of $284,511.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ZOGENIX, INC. No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -16.61K |
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 26
| |||
Form 4
| +28.67% | 3.29K |
$20.70 | -$38,584.80 | 14.78K |
Mar 15
| |||
Form 4
| +104.26% | 5.71K |
—
|
—
| 11.18K |
Jun 25
| |||
Form 4
| -33.76% | -2.57K |
$28.21 | -$72,584.33 | 5.05K |
Scheduled
|
May 12
| ||
Form 4
| +46.98% | 2.44K |
$22.01 | -$26,874.21 | 7.62K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
| -41.33% | -3.45K |
$52.00 | -$179,192.00 | 4.89K |
Scheduled
|
Aug 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 22
| |||
Form 4
| +15.79% | 1.14K |
$51.88 | -$25,317.44 | 8.34K |
Mar 15
| |||
Form 4
|
—
|
0
|
$28.60 | -$203,752.66 | 7.14K |
Scheduled
|
Oct 4
| ||
Form 4
|
—
|
0
|
$30.77 | -$235,322.36 | 7.14K |
Scheduled
|
Sep 4
| ||
Form 4
|
—
|
0
|
$33.29 | -$270,592.59 | 7.14K |
Scheduled
|
Aug 8
| ||
Form 4
| -1.63% | -118.00 |
$29.48 | -$160,510.00 | 7.14K |
Scheduled
|
Jun 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MARINUS PHARMACEUTICALS INC (MRNS) Snapshot price: $1.3911
Chief Clinical Dev & Reg Offic
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$5.26 | -$253,311.00 |
0
|
Scheduled
|
Apr 21
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DURECT CORP (DRRX) Snapshot price: $1.5699
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +123.27% | 55.21K |
$0.40 | $22,012.04 | 100K |
May 16 - May 18
| |||
Form 4
| +85.93% | 20.7K |
$0.40 | $8,258.04 | 44.79K |
May 11 - May 13
| |||
Form 4
| +10.75% | 2.34K |
$0.41 | $949.63 | 24.09K |
May 10
| |||
Form 4
|
∞
| 21.75K |
$0.39 | $8,584.25 | 21.75K |
May 9 - May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVROBIO, Inc. (AVRO) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ProMIS Neurosciences Inc. (PMN) Snapshot price: $1.29
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,659.60% | 53.19K |
—
|
—
| 55.19K |
Aug 23
| |||
Form 4
| +100.00% | 1K |
$4.94 | $4,940.00 | 2K |
Dec 14
| |||
Form 4
|
∞
| 1K |
$5.70 | $5,700.00 | 1K |
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
| No matching records found | |||||||||